Skip to main content
Clinical Trials/NCT04246099
NCT04246099
Completed
Not Applicable

Effect of Opioid-free Anesthesia on Perioperative Period After Video-assisted Thoracoscopic Lobectomy: a Retrospective Study

Hospices Civils de Lyon1 site in 1 country100 target enrollmentMarch 1, 2019
ConditionsThoracicSurgery

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Thoracic
Sponsor
Hospices Civils de Lyon
Enrollment
100
Locations
1
Primary Endpoint
Cumulative dose of postoperative opioid
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No study has been conducted to demonstrate the feasibility and safety of an Opioid-Free Anesthesia (OFA) protocol compared to Opioid-Based Anesthesia (OBA) in thoracic surgery, at risk for intense post-operative pain, to improve patient care. The aim of the present study was to evaluate the effect of OFA on post-operative opioids consumption, pain and the post-operative period after lobectomy by Video-Assisted Thoracoscopy Surgery (VATS). systems.

Investigators perform a retrospective, single-center study in 2019. Patients were divided into two groups: OFA (with dexmedetomidine) or OBA (sufentanyl).

Investigators analyse the total postoperative opioid consumption in the 48 h after surgery. Investigators asses pain intensity in the 48 h after surgery, operative hemodynamic stability, Post-Operative Pain (POP) in Post-Anesthesia Care Unit (PACU) and POP on day 30.

All data are available in the medical record

Hypothesis: OFA can reduce post-operative opioids consumption, pain in lobectomy by video-assisted thoracoscopy surgery (VATS).

Registry
clinicaltrials.gov
Start Date
March 1, 2019
End Date
November 1, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All consecutive patients admitted for lobectomy or wedge video-assisted thoracoscopy
  • Opioid Free Anesthesia (OFA) administration was left to the discretion of the attending anesthetist according to his or her practices and habits.
  • age 18 or over
  • lobectomy or wedge resection by Video-Assisted Thoracoscopy Surgery (VATS)

Exclusion Criteria

  • toxicomania,
  • epidural analgesia use,
  • thoracotomy conversion
  • Patient-Controlled Analgesia with morphine (PCA)
  • Patient who object to take part of the study.

Outcomes

Primary Outcomes

Cumulative dose of postoperative opioid

Time Frame: 48 hours

The primary endpoint was the cumulative dose of postoperative opioid in the first 48 h (D2) (in milligrams of oral morphine equivalent) which included morphine and tramadol after conversion (1mg of intra-veinous morphine = 3 mg of oral morphine, and 10 mg of oral morphine = 50 mg of oral tramadol)

Study Sites (1)

Loading locations...

Similar Trials